Thorac Cardiovasc Surg 2016; 64(01): 053-058
DOI: 10.1055/s-0035-1566235
Original Cardiovascular
Georg Thieme Verlag KG Stuttgart · New York

Custodiol Solution and Cold Blood Cardioplegia in Arterial Switch Operation: Retrospective Analysis in a Single Center

Raffaele Giordano
1   Department of Pediatric Cardiology and Cardiac Surgery, Tuscany Foundation “G. Monasterio,” Massa, MS, Italy
,
Luigi Arcieri
1   Department of Pediatric Cardiology and Cardiac Surgery, Tuscany Foundation “G. Monasterio,” Massa, MS, Italy
,
Massimiliano Cantinotti
1   Department of Pediatric Cardiology and Cardiac Surgery, Tuscany Foundation “G. Monasterio,” Massa, MS, Italy
,
Vitali Pak
1   Department of Pediatric Cardiology and Cardiac Surgery, Tuscany Foundation “G. Monasterio,” Massa, MS, Italy
,
Vincenzo Poli
1   Department of Pediatric Cardiology and Cardiac Surgery, Tuscany Foundation “G. Monasterio,” Massa, MS, Italy
,
Anna Maizza
1   Department of Pediatric Cardiology and Cardiac Surgery, Tuscany Foundation “G. Monasterio,” Massa, MS, Italy
,
Manuel Melo
1   Department of Pediatric Cardiology and Cardiac Surgery, Tuscany Foundation “G. Monasterio,” Massa, MS, Italy
,
Nadia Assanta
1   Department of Pediatric Cardiology and Cardiac Surgery, Tuscany Foundation “G. Monasterio,” Massa, MS, Italy
,
Riccardo Moschetti
1   Department of Pediatric Cardiology and Cardiac Surgery, Tuscany Foundation “G. Monasterio,” Massa, MS, Italy
,
Bruno Murzi
1   Department of Pediatric Cardiology and Cardiac Surgery, Tuscany Foundation “G. Monasterio,” Massa, MS, Italy
› Author Affiliations
Further Information

Publication History

30 July 2015

16 September 2015

Publication Date:
24 November 2015 (online)

Abstract

Background The cardioplegia is one of the most significant tools used to increase myocardial protection. The aim of our study is to compare the use of Custodiol solution versus intermitted blood cardioplegia in a retrospective analysis of data for patients who underwent arterial switch operation in our institution.

Material and Methods From January 2008 to March 2011, myocardial protection was performed in 44 neonates (blood group) with intermittent blood cardioplegia. From March 2011 to November 2014, myocardial protection was performed in 50 neonates (Custodiol group) with one-shot anterograde Custodiol cardioplegia.

Results Cardiopulmonary bypass and aortic cross-clamp were more favorable in Custodiol group (p-value 0.005 and ≤ 0.00001). The rate of delayed sternal closure was 63.6% in the blood group and 52% in the Custodiol group (p = 0.25). In the postoperative outcomes we did not find differences between the two groups. The 30-day mortality was one patient in the blood group (p = 0.46). We observed a transient ischemic electrocardiogram in 10 patients of the blood group and in 14 of the Custodiol group (p = 0.72), all cases with full resolution during hospitalization without coronary reoperation. A trend of higher peak of troponin-I and brain natriuretic peptide in Custodiol group has been reported.

Conclusion No prefect cardioplegia exists, the Custodiol solution does not cause extra/additional myocardial damage in arterial switch operation. In our experience this strategy seems warranted to simplify the procedure and to be more comfortable for the surgeon.

 
  • References

  • 1 von Bernuth G. 25 years after the first arterial switch procedure: mid-term results. Thorac Cardiovasc Surg 2000; 48 (4) 228-232
  • 2 Blume ED, Altmann K, Mayer JE, Colan SD, Gauvreau K, Geva T. Evolution of risk factors influencing early mortality of the arterial switch operation. J Am Coll Cardiol 1999; 33 (6) 1702-1709
  • 3 Gottlieb D, Schwartz ML, Bischoff K, Gauvreau K, Mayer Jr JE. Predictors of outcome of arterial switch operation for complex D-transposition. Ann Thorac Surg 2008; 85 (5) 1698-1702 , discussion 1702–1703
  • 4 Prêtre R, Tamisier D, Bonhoeffer P , et al. Results of the arterial switch operation in neonates with transposed great arteries. Lancet 2001; 357 (9271) 1826-1830
  • 5 Liu J, Feng Z, Zhao J, Li B, Long C. The myocardial protection of HTK cardioplegic solution on the long-term ischemic period in pediatric heart surgery. ASAIO J 2008; 54 (5) 470-473
  • 6 Edelman JJ, Seco M, Dunne B , et al. Custodiol for myocardial protection and preservation: a systematic review. Ann Cardiothorac Surg 2013; 2 (6) 717-728
  • 7 Bretschneider HJ. Myocardial protection. Thorac Cardiovasc Surg 1980; 28 (5) 295-302
  • 8 Calafiore AM, Teodori G, Mezzetti A , et al. Intermittent antegrade warm blood cardioplegia. Ann Thorac Surg 1995; 59 (2) 398-402
  • 9 Hayashida N, Isomura T, Sato T , et al. Minimally diluted tepid blood cardioplegia. Ann Thorac Surg 1998; 65 (3) 615-621
  • 10 Durandy Y, Hulin S. Intermittent warm blood cardioplegia in the surgical treatment of congenital heart disease: clinical experience with 1400 cases. J Thorac Cardiovasc Surg 2007; 133 (1) 241-246
  • 11 Yacoub MH, Radley-Smith R. Anatomy of the coronary arteries in transposition of the great arteries and methods for their transfer in anatomical correction. Thorax 1978; 33 (4) 418-424
  • 12 Hoffman TM, Wernovsky G, Atz AM , et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 2003; 107 (7) 996-1002
  • 13 Hoffman TM, Wernovsky G, Atz AM , et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study. Prophylactic Intravenous Use of Milrinone After Cardiac Operation in Pediatrics. Am Heart J 2002; 143 (1) 15-21
  • 14 Arcieri L, Cantinotti M, Pak V, Bernabei M, Assanta N, Murzi B. V-shape reduction plasty to reduce the neoaortic root-ascending aorta discrepancy in children undergoing arterial switch operation. J Card Surg 2014; 29 (3) 410-412
  • 15 Bretschneider HJ, Hübner G, Knoll D, Lohr B, Nordbeck H, Spieckermann PG. Myocardial resistance and tolerance to ischemia: physiological and biochemical basis. J Cardiovasc Surg (Torino) 1975; 16 (3) 241-260
  • 16 Chambers DJ. Mechanisms and alternative methods of achieving cardiac arrest. Ann Thorac Surg 2003; 75 (2) S661-S666
  • 17 Korun O, Özkan M, Terzi A, Aşkın G, Sezgin A, Aşlamacı S. The comparison of the effects of Bretschneider's histidine-tryptophan-ketoglutarate and conventional crystalloid cardioplegia on pediatric myocardium at tissue level. Artif Organs 2013; 37 (1) 76-81
  • 18 Pouard P, Mauriat P, Ek F , et al. Normothermic cardiopulmonary bypass and myocardial cardioplegic protection for neonatal arterial switch operation. Eur J Cardiothorac Surg 2006; 30 (5) 695-699
  • 19 Angeli E. The crystalloid cardioplegia: advantages with a word of caution. Ann Fr Anesth Reanim 2011; 30 (Suppl. 01) S17-S19
  • 20 Bojan M, Peperstraete H, Lilot M, Tourneur L, Vouhé P, Pouard P. Cold histidine-tryptophan-ketoglutarate solution and repeated oxygenated warm blood cardioplegia in neonates with arterial switch operation. Ann Thorac Surg 2013; 95 (4) 1390-1396
  • 21 Kotani Y, Tweddell J, Gruber P , et al. Current cardioplegia practice in pediatric cardiac surgery: a North American multiinstitutional survey. Ann Thorac Surg 2013; 96 (3) 923-929
  • 22 Durandy Y. Perfusionist strategies for blood conservation in pediatric cardiac surgery. World J Cardiol 2010; 2 (2) 27-33
  • 23 Durandy Y. Pediatric myocardial protection. Curr Opin Cardiol 2008; 23 (2) 85-90
  • 24 Cantinotti M, Law Y, Vittorini S , et al. The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, and management of children with heart failure due to congenital cardiac disease: an update. Heart Fail Rev 2014; 19 (6) 727-742
  • 25 Cantinotti M, Storti S, Lorenzoni V , et al. Response of cardiac endocrine function to surgery stress is age dependent in neonates and children with congenital heart defects: consequences in diagnostic and prognostic accuracy of brain natriuretic peptide measurement. Pediatr Crit Care Med 2013; 14 (5) 508-517
  • 26 Durandy Y, Rubatti M. Warm blood microplegia redosing interval in pediatric surgery. Ann Thorac Surg 2013; 96 (6) 2285-2286